Home »

XIO Group

 Chinese investors of XIO Group acquired medical firm Lumenis for $500 million

xio-lmns.jpgChinese investment firm XIO Group has acquired Israeli medical firm Lumenis for $510 million.

NASDAQ-listed Lumenis provides energy-based, minimally invasive clinical solutions for the surgical, ophthalmology and aesthetic markets. (Its locations include Yokneam, Israel, where surgical and aesthetic products are manufactured, and Salt Lake City, Utah, where ophthalmic products are manufactured). XIO Group is a Hong Kong based alternative investments firm with over $ 3 billion in capital.

XIO Group is listed in the Chinese Private Equity and Venture Capital Directory with the code XJU44

More details follows

More from XIO Group ...

| About Us

SinaBeat.com provides insight, analysis and research on private investors from China since 2012.

We cover Private Equity, Venture Capital, Real Estate and Institutional Investors from China, Hong Kong and Macau.

Our Chinese Investors Directory can be used as a reliable source on information about investors from China.

|Subscribe to mailing list

Enter your email address:

Careers  |  Sponsorship |  Sitemap |  Terms  |  Privacy Policy

Copyright 2007 - 2022     SinaBeat.com

Follow us: RSS  |   SinaBeat on Twitter  |   SinaBeat on Facebook  |   SinaBeat on LinkedIn